Zdrowie i gospodarka · 16/04/2026
FDA Reclassifies Non-Invasive Bone Growth Stimulators
The FDA is reclassifying non-invasive bone growth stimulators, currently classified as Class III devices, into Class II devices, subject to premarket notification, and establishing special controls for safety and effectiveness.
Source: Federal Register — Food and Drug AdministrationOpen original release →